Endpoint Outcomes Adopts Lumanity Branding After Acquisition

Lumanity’s most recent acquisition, Endpoint Outcomes, will be folded into the company’s overall brand. The move fully integrates Endpoint’s health economics and outcomes research (HEOR) expertise into Lumanity, expanding its reach into the HEOR field, with an emphasis on the US market. In addition, the Lumanity’s HEOR team will broaden its services in Europe to help meet HTA processes and payer decision-making.

According to , “The HEOR team is now active in the Lumanity Patient Center of Excellence, amplifying the geographic reach of its patient-centered outcomes capabilities and extending its impact across the drug development lifecycle. The Center of Excellence facilitates the sharing of best practices, drives innovation, and ensures the company is providing clients with industry-leading patient engagement and partnership.”

To read more, click here.

(Source: StreetInsider.com, September 26^th, 2022)